Linhui Pan
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma.
Journal: Transplant immunology
Published: July 27, 2023
Dynamic immune cell profiling identified natural killer cell shift as the key event in early allograft dysfunction after liver transplantation.
Journal: Cell proliferation
Published: December 04, 2022
Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: October 17, 2022
Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer.
Journal: Redox biology
Published: July 13, 2022
Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.
Journal: American journal of cancer research
Published: April 06, 2022
Comparison of modified MAZE with minimally invasive monopolar ablation and traditional bipolar radiofrequency ablation in the treatment of atrial fibrillation.
Journal: Journal of cardiothoracic surgery
Published: March 21, 2019
USP14 promotes K63-linked RIG-I deubiquitination and suppresses antiviral immune responses.
Journal: European journal of immunology
Published: March 15, 2018
The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation.
Journal: Gene
Published: February 02, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026